欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号BE/H/0084/003
药品名称Viraferon
活性成分
    • [No Active-Substance specified] 0.0 -
剂型Powder for solution for injection
上市许可持有人Schering-Plough NV/SA Rue de Stalle 73 1180 Bruxelles
参考成员国 - 产品名称Belgium (BE)
互认成员国 - 产品名称
    • Germany (DE)
      Viraferon HSA containing 5 MIU/ml, powder for solution
    • Denmark (DK)
      Viraferon HSA containing 5 MIU/ml, powder for solution
    • Netherlands (NL)
      Viraferon HSA containing 5 MIU/ml, powder for solution
    • Luxembourg (LU)
      Viraferon
    • United Kingdom (Northern Ireland) (XI)
      Viraferon HSA containing 5 MIU/ml, powder for solution
    • Ireland (IE)
      Viraferon HSA containing 5 MIU/ml, powder for solution
    • Austria (AT)
      Viraferon HSA containing 5 MIU/ml, powder for solution
    • France (FR)
      Viraferon HSA containing 5 MIU/ml, powder for solution
    • Spain (ES)
      Viraferon HSA containing 5 MIU/ml, powder for solution
    • Portugal (PT)
      Viraferon HSA containing 5 MIU/ml, powder for solution
    • Italy (IT)
      Viraferon HSA containing 5 MIU/ml, powder for solution
    • Greece (GR)
      Viraferon HSA containing 5 MIU/ml, powder for solution
    • Sweden (SE)
      Viraferon HSA containing 5 MIU/ml, powder for solution
    • Finland (FI)
      Viraferon HSA containing 5 MIU/ml, powder for solution
许可日期2008/04/05
最近更新日期2008/04/05
药物ATC编码
    • L03A IMMUNOSTIMULANTS
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase